Company / Shareholders' Equity
Neogen Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$2.1B
FY2025
5-year range
$840.4M / $3.1B
FY2021-FY2025
Trend
-34.1%
vs FY2024
Sector context
#55 of 166
Health Care
What the data says
At $2.1B, Neogen's shareholders' equity ranks #55 of 166 in the Health Care sector. Declined from $3.1B to $2.1B over the past 2 years.
Based on SEC 10-K filings.
$2.1B in FY2025 with a 5-year CAGR of +23.4%.
Declined from $3.1B to $2.1B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +32.7%
- 5-Year CAGR
- +23.4%
- 10-Year CAGR
- -
Sector benchmark
#55 of 166 in Health CareTop 33% of 166This company $2.1B Sector average $5.3B
▼
-60.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.4%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 34.1% year-over-year.
- Ranks #55 out of 166 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.1B | -34.1% |
| FY2024 | $3.1B | +0.3% |
| FY2023 | $3.1B | +253.2% |
| FY2022 | $887.4M | +5.6% |
| FY2021 | $840.4M | +15.9% |
| FY2020 | $725.2M | +13.7% |
| FY2019 | $637.9M | +13.9% |
| FY2018 | $560.2M | +18.8% |
| FY2017 | $471.6M | +16.7% |
| FY2016 | $404.2M | +15.2% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026